Cargando…
Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
BACKGROUND: Glioblastoma is devastating cancer with a high frequency of occurrence and poor survival rate and it is urgent to discover novel glioblastoma-specific antigens for the therapy. Cancer-germline genes are known to be related to the formation and progression of several cancer types by promo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368788/ https://www.ncbi.nlm.nih.gov/pubmed/32682409 http://dx.doi.org/10.1186/s12885-020-07155-y |